Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome

American Journal of Pathology

Volumn 180, Issue 3, 2012, Pages 1040-1048

  Ramos, Maria V ^a   Auvynet, Constance ^b   Poupel, Lucie ^b   Rodero, Mathieu ^b   Mejias, Maria Pilar ^a   Panek, Cecilia A ^a   Vanzulli, Silvia ^a   Combadiere, Christophe ^b   Palermo, Marina ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; INTERLEUKIN 6; SHIGA TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; HEMOLYTIC UREMIC SYNDROME; INFLAMMATION; KIDNEY INJURY; MONOCYTOSIS; MOUSE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; BONE MARROW; CREATINE; HEMOLYTIC-UREMIC SYNDROME; INTERLEUKIN-6; KIDNEY TUBULES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MYELOID CELLS; RECEPTORS, CCR1; SHIGA TOXIN 2; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA; UREA;

EID: 84857215617     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.11.011     Document Type: Article

References (49)

1. M. Noris, G. Remuzzi Hemolytic uremic syndrome J Am Soc Nephrol 16 2005 1035 1050
2. P.I. Tarr, C.A. Gordon, W.L. Chandler Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome Lancet 365 2005 1073 1086
3. R. Siegler, R. Oakes Hemolytic uremic syndrome: pathogenesis, treatment, and outcome Curr Opin Pediatr 17 2005 200 204
4. M. Rivas, E. Miliwebsky, I. Chinen, N. Deza, G.A. Leotta The epidemiology of hemolytic uremic syndrome in Argentina: diagnosis of the etiologic agent, reservoirs and routes of transmission [in Spanish] Medicina (B Aires) 66 Suppl 3 2006 27 32
5. P.S. Mead, P.M. Griffin Escherichia coli O157: H7 Lancet 352 1998 1207 1212
6. P. Ruggenenti, M. Noris, G. Remuzzi Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura Kidney Int 60 2001 831 846
7. P.A. van Setten, V.W. van Hinsbergh, T.J. van der Velden, N.C. van de Kar, M. Vermeer, J.D. Mahan, K.J. Assmann, L.P. van den Heuvel, L.A. Monnens Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells Kidney Int 51 1997 1245 1256
8. P.A. van Setten, L.A. Monnens, R.G. Verstraten, L.P. van den Heuvel, V.W. van Hinsbergh Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release Blood 88 1996 174 183
9. G.C. Fernandez, M.F. Lopez, S.A. Gomez, M.V. Ramos, L.V. Bentancor, R.J. Fernandez-Brando, V.I. Landoni, G.I. Dran, R. Meiss, M.A. Isturiz, M.S. Palermo Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia Clin Exp Immunol 146 2006 76 84
10. M.S. Palermo, M.F. Alves Rosa, N. Van Rooijen, M.A. Isturiz Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model Clin Exp Immunol 116 1999 462 467
11. M.M. Fitzpatrick, V. Shah, R.S. Trompeter, M.J. Dillon, T.M. Barratt Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood Kidney Int 42 1992 951 956
12. K.D. Forsyth, A.C. Simpson, M.M. Fitzpatrick, T.M. Barratt, R.J. Levinsky Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome Lancet 2 1989 411 414
13. C.D. Inward, A.J. Howie, M.M. Fitzpatrick, F. Rafaat, D.V. Milford, C.M. Taylor British Association for Paediatric Nephrology Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome Pediatr Nephrol 11 1997 556 559
14. P.A. van Setten, V.W. van Hinsbergh, L.P. van den Heuvel, F. Preyers, H.B. Dijkman, K.J. Assmann, T.J. van der Velden, L.A. Monnens Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome Pediatr Res 43 1998 759 767
15. J.K. Roche, T.R. Keepers, L.K. Gross, R.M. Seaner, T.G. Obrig CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157: H7-associated renal inflammation Am J Pathol 170 2007 526 537
16. C. Zoja, S. Angioletti, R. Donadelli, C. Zanchi, S. Tomasoni, E. Binda, B. Imberti, M. te Loo, L. Monnens, G. Remuzzi, M. Morigi Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1 Kidney Int 62 2002 846 856
17. M.V. Ramos, G.C. Fernandez, N. Patey, P. Schierloh, R. Exeni, I. Grimoldi, G. Vallejo, C. Elias-Costa, M. Del Carmen Sasiain, H. Trachtman, C. Combadiere, F. Proulx, M.S. Palermo Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome Blood 109 2007 2438 2445
18. C. Zanchi, C. Zoja, M. Morigi, F. Valsecchi, X.Y. Liu, D. Rottoli, M. Locatelli, S. Buelli, A. Pezzotta, P. Mapelli, J. Geelen, G. Remuzzi, J. Hawiger Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin J Immunol 181 2008 1460 1469
19. H.J. Anders, V. Ninichuk, D. Schlondorff Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists Kidney Int 69 2006 29 32
20. K. Neote, D. DiGregorio, J.Y. Mak, R. Horuk, T.J. Schall Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor Cell 72 1993 415 425
21. J.L. Gao, P.M. Murphy Cloning and differential tissue-specific expression of three mouse beta chemokine receptor-like genes, including the gene for a functional macrophage inflammatory protein-1 alpha receptor J Biol Chem 270 1995 17494 17501
22. J.L. Gao, A.I. Sen, M. Kitaura, O. Yoshie, M.E. Rothenberg, P.M. Murphy, A.D. Luster Identification of a mouse eosinophil receptor for the CC chemokine eotaxin Biochem Biophys Res Commun 223 1996 679 684
23. T.R. Keepers, L.K. Gross, T.G. Obrig Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome Infect Immun 75 2007 1229 1236
24. J.M. Danforth, R.M. Strieter, S.L. Kunkel, D.A. Arenberg, G.M. VanOtteren, T.J. Standiford Macrophage inflammatory protein-1 alpha expression in vivo and in vitro: the role of lipoteichoic acid Clin Immunol Immunopathol 74 1995 77 83
25. J.L. Gao, D.B. Kuhns, H.L. Tiffany, D. McDermott, X. Li, U. Francke, P.M. Murphy Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor J Exp Med 177 1993 1421 1427
26. T. Kasama, R.M. Strieter, T.J. Standiford, M.D. Burdick, S.L. Kunkel Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha J Exp Med 178 1993 63 72
27. W.A. Kuziel, T.C. Dawson, M. Quinones, E. Garavito, G. Chenaux, S.S. Ahuja, R.L. Reddick, N. Maeda CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice Atherosclerosis 167 2003 25 32
28. A.V. Capozzo, V. Pistone Creydt, G. Dran, G. Fernandez, S. Gomez, L.V. Bentancor, C. Rubel, C. Ibarra, M. Isturiz, M.S. Palermo Development of DNA vaccines against hemolytic-uremic syndrome in a murine model Infect Immun 71 2003 3971 3978
29. M.A. Karmali, M. Petric, C. Lim, P.C. Fleming, G.S. Arbus, H. Lior The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli J Infect Dis 151 1985 775 782
30. A.S. Awad, M. Rouse, L. Huang, A.L. Vergis, J. Reutershan, H.P. Cathro, J. Linden, M.D. Okusa Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury Kidney Int 75 2009 689 698
31. D. Bedoret, H. Wallemacq, T. Marichal, C. Desmet, F. Quesada Calvo, E. Henry, R. Closset, B. Dewals, C. Thielen, P. Gustin, L. de Leval, N. Van Rooijen, A. Le Moine, A. Vanderplasschen, D. Cataldo, P.V. Drion, M. Moser, P. Lekeux, F. Bureau Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice J Clin Invest 119 2009 3723 3738
32. H.J. Anders, M. Frink, Y. Linde, B. Banas, M. Wornle, C.D. Cohen, V. Vielhauer, P.J. Nelson, H.J. Grone, D. Schlondorff CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration J Immunol 170 2003 5658 5666
33. D. Paixao-Cavalcante, M. Botto, H.T. Cook, M.C. Pickering Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice Clin Exp Immunol 155 2009 339 347
34. H.J. Anders, V. Vielhauer, M. Frink, Y. Linde, C.D. Cohen, S.M. Blattner, M. Kretzler, F. Strutz, M. Mack, H.J. Grone, J. Onuffer, R. Horuk, P.J. Nelson, D. Schlondorff A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation J Clin Invest 109 2002 251 259
35. V. Eis, B. Luckow, V. Vielhauer, J.T. Siveke, Y. Linde, S. Segerer, G. Perez De Lema, C.D. Cohen, M. Kretzler, M. Mack, R. Horuk, P.M. Murphy, J.L. Gao, K.L. Hudkins, C.E. Alpers, H.J. Grone, D. Schlondorff, H.J. Anders Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction J Am Soc Nephrol 15 2004 337 347
36. H.J. Anders, E. Belemezova, V. Eis, S. Segerer, V. Vielhauer, G. Perez de Lema, M. Kretzler, C.D. Cohen, M. Frink, R. Horuk, K.L. Hudkins, C.E. Alpers, F. Mampaso, D. Schlondorff Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice J Am Soc Nephrol 15 2004 1504 1513
37. X. Shang, B. Qiu, K.A. Frait, J.S. Hu, J. Sonstein, J.L. Curtis, B. Lu, C. Gerard, S.W. Chensue Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation Am J Pathol 157 2000 2055 2063
38. J.L. Gao, T.A. Wynn, Y. Chang, E.J. Lee, H.E. Broxmeyer, S. Cooper, H.L. Tiffany, H. Westphal, J. Kwon-Chung, P.M. Murphy Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 J Exp Med 185 1997 1959 1968
39. T.L. Ness, K.J. Carpenter, J.L. Ewing, C.J. Gerard, C.M. Hogaboam, S.L. Kunkel CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis J Immunol 173 2004 6938 6948
40. C.D. Inward, M. Varagunam, D. Adu, D.V. Milford, C.M. Taylor Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection Arch Dis Child 77 1997 145 147
41. A. Murata, T. Shimazu, T. Yamamoto, N. Taenaka, K. Nagayama, T. Honda, H. Sugimoto, M. Monden, N. Matsuura, S. Okada Profiles of circulating inflammatory- and anti-inflammatory cytokines in patients with hemolytic uremic syndrome due to E. coli O157 infection Cytokine 10 1998 544 548
42. D. Ferenbach, D.C. Kluth, J. Hughes Inflammatory cells in renal injury and repair Semin Nephrol 27 2007 250 259
43. + cells impairs the recovery process in ischaemia/reperfusion-induced acute kidney injury Nephrol Dial Transplant 25 2010 2908 2921
44. G.C. Fernandez, C. Rubel, G. Dran, S. Gomez, M.A. Isturiz, M.S. Palermo Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome Clin Immunol 95 2000 227 234
45. D. Karpman, A. Andreasson, H. Thysell, B.S. Kaplan, C. Svanborg Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura Pediatr Nephrol 9 1995 694 699
46. A.K. Hughes, P.K. Stricklett, D.E. Kohan Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells Nephron 88 2001 14 23
47. G.H. Foster, C.S. Armstrong, R. Sakiri, V.L. Tesh Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases Infect Immun 68 2000 5183 5189
48. M. Palermo, F. Alves-Rosa, C. Rubel, G.C. Fernandez, G. Fernandez-Alonso, F. Alberto, M. Rivas, M. Isturiz Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality Clin Exp Immunol 119 2000 77 83
49. M. Michael, E.J. Elliott, J.C. Craig, G. Ridley, E.M. Hodson Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials Am J Kidney Dis 53 2009 259 272